AdaptHealth Corp. (AHCO) - Dilution Analysis

10-Q filing | 135.8M shares outstanding

10-Q filing | 135.3M shares outstanding

10-Q filing | 135.0M shares outstanding

10-Q filing | 134.8M shares outstanding

10-K filing | 135.5M shares outstanding

10-Q filing | 134.3M shares outstanding

10-Q filing | 133.2M shares outstanding

10-Q filing | 132.9M shares outstanding

10-K filing | 134.2M shares outstanding

10-Q filing | 135.0M shares outstanding

10-Q filing | 136.2M shares outstanding

10-Q filing | 134.5M shares outstanding

10-K filing | 134.2M shares outstanding

10-Q filing | 134.2M shares outstanding

10-Q filing | 134.3M shares outstanding

10-Q filing | 134.0M shares outstanding

10-K filing | 133.0M shares outstanding

10-Q filing | 131.7M shares outstanding

10-Q filing | 76.5M shares outstanding

S-3 filing: Registration of 27,040,088 shares of Class A Common Stock for resale by selling stockholders.

10-Q filing | 76.5M shares outstanding

10-K filing | 76.5M shares outstanding

8-K filing: AdaptHealth Corp. sold 8,450,000 shares of Class A common stock through an underwriting agreement with Deutsche Bank Securities Inc. and Jefferies LLC, with the Underwriters exercising their option to purchase an additional 1,200,000 shares.

S-3 filing: This is an S-3 filing for a secondary offering of Class A Common Stock, warrants, and a combination offering of various securities with an aggregate offering price not to exceed $500,000,000.

10-Q filing | 40.8M shares outstanding

10-Q filing | 44.5M shares outstanding

S-1 filing: This S-1 filing relates to the offer and sale of up to 2,545,455 shares of Class A Common Stock by the selling securityholder, issuable upon conversion of Series B-1 and B-2 Preferred Stock.

8-K filing: AdaptHealth Corp. completed the issuance and sale of 10,930,471 shares of Class A Common Stock and 39,706 shares of Series A Preferred Stock to OEP AHCO Investment Holdings, LLC, and the issuance and sale of 35,000 shares of Series B-2 Preferred Stock to Deerfield Partners.

S-1 filing: This S-1 filing is for a proposed equity offering by AdaptHealth Corp. The document describes an agreement between AdaptHealth and several underwriters for the issuance and sale of firm shares, with an option for the underwriters to purchase additional shares. It details the terms of the offering, including compliance with registration requirements, disclosure accuracy, and various legal and financial representations and warranties by the company.

8-K filing: AdaptHealth Corp. entered into an Exchange Agreement with Deerfield Private Design Fund IV, exchanging 15,810,547 shares of Class A Common Stock for 158,105.47 shares of Series B-1 Convertible Preferred Stock; and entered into an Investment Agreement with Deerfield Partners for the purchase of $35,000,000 in Series B-2 Convertible Preferred Stock. ($35.0M proceeds)

8-K filing: AdaptHealth Corp. enters into a Stock Purchase Agreement and Investment Agreement to acquire Solara Holdings, issuing 3,906,250 shares of Class A Common Stock and up to $190,000,000 in Class A Common Stock and Series A Convertible Preferred Stock to OEP AHCO Investment Holdings, LLC. ($62.5M proceeds)

10-Q filing | 45.4M shares outstanding

S-1/A filing: This S-1/A filing includes a secondary offering of 75,053,512 shares of Class A Common Stock and 4,333,333 Warrants to Purchase Class A Common Stock. It also covers the issuance of up to 9,601,909 shares of Class A Common Stock upon warrant exercise.

10-K filing | 42.2M shares outstanding

S-1/A filing: This is an S-1/A filing for a secondary offering of Class A Common Stock and Warrants to Purchase Class A Common Stock.

S-3 filing: The filing is an S-3 registration statement for AdaptHealth Corp. relating to the primary offering of shares of Class A Common Stock issuable upon exercise of warrants and a secondary offering of shares of Class A Common Stock and warrants to purchase Class A Common Stock by selling securityholders.